IntelliAM aiming for significant growth with £5 million Aquis IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPorvair Regulatory News (PRV)

Share Price Information for Porvair (PRV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 646.00
Bid: 646.00
Ask: 650.00
Change: 6.00 (0.94%)
Spread: 4.00 (0.619%)
Open: 650.00
High: 654.00
Low: 642.00
Prev. Close: 640.00
PRV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading update & appointment of an Independent NED

21 Sep 2016 07:00

RNS Number : 3721K
Porvair PLC
21 September 2016
 

For immediate release 21 September 2016

 

 

Porvair plc

 

Nine months trading update and appointment of an Independent Non-Executive Director

 

Porvair plc ("Porvair"), the specialist filtration and environmental technology group, today issues the following trading update for the nine months ended 31 August 2016.

Porvair continues to trade well. Revenues at constant currency for the nine months ended 31 August 2016 were 8% higher than in the nine months to 31 August 2015. Profit before tax was ahead of the prior year and in line with management's expectations.

The Microfiltration division was the main contributor to growth. Aerospace revenues are at record levels and the US acquisition, TEM, made earlier in the year has traded well. Metals Filtration has returned to growth in the third quarter of the year after a slower start and production in the new facility in China is going well.

The significant weakening of Sterling in the third quarter will improve the Group's full year reported revenue growth but, as a result of forward currency sales contracted early in the financial year, is expected to have little impact on full year earnings in 2016.

At 31 August 2016, the Group had net cash of £6m (31 August 2015: £9m) with the £2.9m paid for the acquisition of TEM largely accounting for the difference. Order books for the final quarter are healthy.

The Board is pleased to announce the appointment of Sally Martin as an Independent Non-Executive Director with effect from 1 October 2016. Sally will join the Audit Committee, Remuneration Committee and Nominations Committee of Porvair.

Sally Martin is Vice President for Health, Safety, Security and Environmental in the Downstream division of Shell International Petroleum. In a thirty-year career with Shell, Sally has built a strong track record in strategy; M&A; international business development; and engineering and operations. She is a member of the Chartered Institute of Electrical Engineers.

Porvair confirms that there are no further matters to be disclosed pursuant to the requirements of paragraph 9.6.13 of the Listing Rules of the UK Listing Authority.

 

 

 

For further information, please contact:

 

Porvair plc

01553 765 500

Ben Stocks, Chief Executive

 

Chris Tyler, Group Finance Director

 

 

 

Buchanan Communications

0207 466 5000

Charles Ryland / Stephanie Watson

 

 

Notes to Editors

Porvair is a group of specialist filtration and environmental technology businesses. Its businesses design and manufacture a range of bespoke consumable filtration products that are used in a range of niche filtration markets. Its principal markets are aviation, energy and industrial process, environmental laboratories and non-ferrous metals.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCURVVRNKAKUAR
Date   Source Headline
13th Sep 20227:00 amRNSNine Month Trading Update
9th Sep 20224:40 pmRNSSecond Price Monitoring Extn
9th Sep 20224:35 pmRNSPrice Monitoring Extension
8th Sep 20224:40 pmRNSSecond Price Monitoring Extn
8th Sep 20224:35 pmRNSPrice Monitoring Extension
7th Sep 20226:05 pmRNSDirector/PDMR Shareholding
6th Sep 20224:40 pmRNSHolding(s) in Company
2nd Sep 20223:06 pmRNSHolding(s) in Company
10th Aug 20224:40 pmRNSSecond Price Monitoring Extn
10th Aug 20224:36 pmRNSPrice Monitoring Extension
9th Aug 20224:36 pmRNSPrice Monitoring Extension
8th Jul 20227:00 amRNSDirector Declaration
5th Jul 20224:35 pmRNSPrice Monitoring Extension
4th Jul 20227:00 amRNSHalf Year Results 2022
30th Jun 20222:15 pmRNSDirector/PDMR Shareholding
29th Apr 20224:41 pmRNSSecond Price Monitoring Extn
29th Apr 20224:36 pmRNSPrice Monitoring Extension
28th Apr 20227:00 amRNSDirector/PDMR Shareholding
14th Apr 20221:42 pmRNSAGM resolutions
14th Apr 20227:00 amRNSAGM Trading Update
11th Mar 20224:41 pmRNSSecond Price Monitoring Extn
11th Mar 20224:36 pmRNSPrice Monitoring Extension
2nd Mar 20224:35 pmRNSPrice Monitoring Extension
28th Feb 20227:00 amRNSBlock listing Interim Review
28th Feb 20227:00 amRNSTotal Voting Rights
4th Feb 20223:00 pmRNSDirector/PDMR Shareholding
4th Feb 202212:20 pmRNSGrant of LTSP awards
3rd Feb 202211:27 amRNSDirector/PDMR Shareholding
31st Jan 20227:00 amRNSResults for the year ended 30 November 2021
14th Dec 202112:25 pmRNSDirector Declaration
9th Dec 20217:00 amRNSPre-close trading update and Notice of Results
23rd Nov 202112:30 pmRNSHolding(s) in Company
5th Nov 20214:40 pmRNSSecond Price Monitoring Extn
5th Nov 20214:35 pmRNSPrice Monitoring Extension
8th Oct 20214:40 pmRNSSecond Price Monitoring Extn
8th Oct 20214:35 pmRNSPrice Monitoring Extension
27th Sep 20214:41 pmRNSSecond Price Monitoring Extn
27th Sep 20214:35 pmRNSPrice Monitoring Extension
16th Sep 20213:31 pmRNSDirector/PDMR Shareholding
14th Sep 20217:00 amRNSNine Month Trading Update
11th Aug 20214:41 pmRNSSecond Price Monitoring Extn
11th Aug 20214:35 pmRNSPrice Monitoring Extension
10th Aug 20214:40 pmRNSSecond Price Monitoring Extn
10th Aug 20214:35 pmRNSPrice Monitoring Extension
4th Aug 20217:00 amRNSBlock listing Interim Review
5th Jul 20217:00 amRNSHalf Year Results 2021
30th Jun 20217:00 amRNSTotal Voting Rights
29th Jun 20214:41 pmRNSSecond Price Monitoring Extn
29th Jun 20214:36 pmRNSPrice Monitoring Extension
23rd Jun 20214:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.